Trump adviser described as ‘key architect’ of drug-pricing blueprint to step down

0
23


John O’Brien, a former insurance industry executive, will step down less than one year after his appointment as senior advisory to HHS Secretary Alex Azar on drug-pricing reform. He had worked for HHS since March 2017 and also previously worked for CMS.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here